TVM Capital announces $17 M investment into neurocare to improve healthcare access in Middle East

TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and Singapore, has announced a $17 million investment into Munich-headquartered neurocare group AG (neurocare), a leading innovator in personalised mental healthcare, providing solutions to empower clinicians to deliver best care to their patients.

TVM Capital Healthcare's investment will enable neurocare to execute on its international growth plans, including expansion in the US and market entry into the Kingdom of Saudi Arabia, as well as support the development of new hardware and software innovations. It is the ninth investment of TVM Capital Healthcare to improve local access to quality healthcare in the Middle East and North Africa (MENA) region.

neurocare, through its digital therapy platform (DTP), provides a holistic and patient centric treatment for a variety of psychological or neurological conditions. It uses innovative mental healthcare methods and tools including sleep assessment, therapeutics, psychotherapy, TMS and neurofeedback, all supervised within a cloud-based solution, to empower clinicians and deliver individualised care. neurocare's offering is used in the Company's own clinics in the US, Europe and Australia, as well as in a growing number of third-party clinics.